Suvasini Ramaswamy

1.0k citations
7 papers · 779 indexed · 1 hit paper · h-index 6

Suvasini Ramaswamy

7 papers receiving 759 citations

Hit Papers

Hybrid Periportal Hepatocytes Regenerate the Injured Live...3612015202620182022100200300

Peers

Suvasini Ramaswamy
Comparison fields: 5 of 76
  • Hepatology 236
  • Cancer Research 142
  • Molecular Biology 471
  • Surgery 203
  • Genetics 109
Replace Yuko Tsukahara with:
Yuko Tsukahara Japan
Andrea Franconi France
Amy E. Hanlon Newell United States
Nathalie Lin-Marq Switzerland
R.L. Belote United States
María Vila-Casadesús Spain
Leander Blaas Austria
Sean P. McCarthy United Kingdom
Erik Wendlandt United States
Suvasini Ramaswamy relative to Yuko Tsukahara Japan Yuko Tsukahara's profile →
Citations per field
00.5×2.9×
Yuko Tsukahara · 1×
Citations per year

Countries citing papers authored by Suvasini Ramaswamy

Since Specialization
Citations

This map shows the geographic impact of Suvasini Ramaswamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvasini Ramaswamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvasini Ramaswamy more than expected).

Fields of papers citing papers by Suvasini Ramaswamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suvasini Ramaswamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvasini Ramaswamy. The network helps show where Suvasini Ramaswamy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suvasini Ramaswamy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suvasini Ramaswamy Line = papers co-authored together Suvasini Ramaswamy links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 20185
2 201830
3 2017236
4
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancerbreakdown →
2015361
5 20151
6 2011133
7 201013

About Suvasini Ramaswamy

Suvasini Ramaswamy is a scholar working on Hepatology, Biochemistry and Cancer Research, having authored 7 papers that have together received 779 indexed citations. Recurring topics across this work include Virus-based gene therapy research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pancreatic function and diabetes (2 papers), Liver physiology and pathology (2 papers), RNA Interference and Gene Delivery (1 paper), Neuroblastoma Research and Treatments (1 paper), Hemophilia Treatment and Research (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Hepatology (236 citations), Cancer Research (142 citations) and Molecular Biology (471 citations). Suvasini Ramaswamy has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Inder M. Verma, Nina Tonnu, Kiyoshi Tachikawa, Pattraranee Limphong, Priya Karmali, Jerel Vega, Pad Chivukula, Mark A. Valasek, Joan Font-Burgada and Janel L. Kopp. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026